SenzaGen is a spin out company from Lund University with expertise in immunology, technology and genomics. SenzaGen markets, sells and performs the in vitro GARD sensitization test through its own laboratory and through licenced CROs.As a scientific quality-orientated and innovative international company, SenzaGen supports its clients with stringent quality assessments. The GARD test is recommended by ECHA and accepted by OECD for validation.
